182 related articles for article (PubMed ID: 28676319)
1. Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction.
Billon R; Bosc R; Belkacemi Y; Assaf E; SidAhmed-Mezi M; Hersant B; Meningaud JP
J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1495-1504. PubMed ID: 28676319
[TBL] [Abstract][Full Text] [Related]
2. Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?
Jokuszies A; Radtke C; Betzler C; Branski L; Krämer R; Vogt PM
Ger Med Sci; 2013; 11():Doc05. PubMed ID: 23423877
[TBL] [Abstract][Full Text] [Related]
3. Risk of perioperative hormonal breast cancer therapy for microvascular flap complications in breast reconstruction.
Mahrhofer M; Reichert R; Siegwart LC; Russe E; Schoeller T; Wechselberger G; Weitgasser L
J Plast Reconstr Aesthet Surg; 2023 Oct; 85():143-148. PubMed ID: 37487260
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen (selective estrogen-receptor modulators) and aromatase inhibitors as potential perioperative thrombotic risk factors in free flap breast reconstruction.
Mirzabeigi MN; Nelson JA; Fischer JP; Kovach SJ; Serletti JM; Wu LC; Kanchwala S
Plast Reconstr Surg; 2015 Apr; 135(4):670e-679e. PubMed ID: 25811579
[TBL] [Abstract][Full Text] [Related]
5. Microvascular breast reconstruction and thromboembolic events in patients on hormone therapy: Audit of practice from a tertiary referral centre.
Samaras S; Ashfield S; Ali SF; Fopp LJ; Benson JR; Malata CM
J Plast Reconstr Aesthet Surg; 2021 May; 74(5):957-965. PubMed ID: 33221183
[TBL] [Abstract][Full Text] [Related]
6. Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based Microsurgical Breast Reconstruction?
Tran BNN; Ruan QZ; Cohen JB; Kamali P; Doval AF; Tobias AM; Singhal D; Lin SJ; Lee BT
Plast Reconstr Surg; 2018 Jun; 141(6):805e-813e. PubMed ID: 29794694
[TBL] [Abstract][Full Text] [Related]
7. Bilateral Free Flap Breast Reconstruction After Unilateral Radiation: Comparing Intraoperative Vascular Complications and Postoperative Outcomes in Radiated Versus Nonradiated Breasts.
Fracol ME; Basta MN; Nelson JA; Fischer JP; Wu LC; Serletti JM; Fosnot J
Ann Plast Surg; 2016 Mar; 76(3):311-4. PubMed ID: 26545214
[TBL] [Abstract][Full Text] [Related]
8. Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis.
Parikh RP; Odom EB; Yu L; Colditz GA; Myckatyn TM
Breast Cancer Res Treat; 2017 May; 163(1):1-10. PubMed ID: 28185144
[TBL] [Abstract][Full Text] [Related]
9. Safe perioperative tamoxifen use in autologous breast free flap reconstruction: systematic review and meta-analysis.
Webster TK; Roth SC; Yu D; Baltodano PA; Araya S; Elmer NA; Kaplunov BS; Massada KE; Talemal L; Hackley M; Patel SA
Breast Cancer Res Treat; 2022 Jun; 193(2):241-251. PubMed ID: 35286525
[TBL] [Abstract][Full Text] [Related]
10. Flap Failure and Wound Complications in Autologous Breast Reconstruction: A National Perspective.
Massenburg BB; Sanati-Mehrizy P; Ingargiola MJ; Rosa JH; Taub PJ
Aesthetic Plast Surg; 2015 Dec; 39(6):902-9. PubMed ID: 26487657
[TBL] [Abstract][Full Text] [Related]
11. Perioperative Use of Antiestrogen Therapies in Breast Reconstruction: A Systematic Review and Treatment Recommendations.
Spera LJ; Cook JA; Dolejs S; Fisher C; Lester ME; Hassanein AH
Ann Plast Surg; 2020 Oct; 85(4):448-455. PubMed ID: 32332390
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of delayed abdominal-based autologous reconstruction versus latissimus dorsi flap plus implant reconstruction in previously irradiated patients.
Levine SM; Patel N; Disa JJ
Ann Plast Surg; 2012 Oct; 69(4):380-2. PubMed ID: 22964681
[TBL] [Abstract][Full Text] [Related]
13. Perforator flap breast reconstruction after unsatisfactory implant reconstruction.
Levine SM; Lester ME; Fontenot B; Allen RJ
Ann Plast Surg; 2011 May; 66(5):513-7. PubMed ID: 21301299
[TBL] [Abstract][Full Text] [Related]
14. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
15. The differential effect of BMI on prosthetic versus autogenous breast reconstruction: a multivariate analysis of 12,986 patients.
Hanwright PJ; Davila AA; Hirsch EM; Khan SA; Fine NA; Bilimoria KY; Kim JY
Breast; 2013 Oct; 22(5):938-45. PubMed ID: 23769660
[TBL] [Abstract][Full Text] [Related]
16. Immediate breast reconstruction surgery with expander/direct implant and use of acellular dermal matrix: Does hormone therapy increases the risk of infection?
Danino MA; Giaccone D; El Khatib A; Dimitropoulos G; Doucet O; Gagnon A; Retchkiman M; Bou-Merhi J; Bernier C
Ann Chir Plast Esthet; 2020 Jul; 65(4):277-283. PubMed ID: 32493612
[TBL] [Abstract][Full Text] [Related]
17. An assessment of the risks and benefits of immediate autologous breast reconstruction in patients undergoing postmastectomy radiation therapy.
Mirzabeigi MN; Smartt JM; Nelson JA; Fosnot J; Serletti JM; Wu LC
Ann Plast Surg; 2013 Aug; 71(2):149-55. PubMed ID: 23542828
[TBL] [Abstract][Full Text] [Related]
18. Topical Estrogen Prescription Fill Rates for Women With a History of Breast Cancer Who Are Taking Hormone Therapy.
Huntley JH; Richter LA; Blackford AL; Aliu O; Pollack CE
Obstet Gynecol; 2018 Nov; 132(5):1137-1142. PubMed ID: 30303924
[TBL] [Abstract][Full Text] [Related]
19. Management of mastectomy skin flap necrosis in autologous breast reconstruction.
Nykiel M; Sayid Z; Wong R; Lee GK
Ann Plast Surg; 2014 May; 72 Suppl 1():S31-4. PubMed ID: 24667879
[TBL] [Abstract][Full Text] [Related]
20. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M
Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
